Peri-Ureteral Urothelial Carcinoma Confined to the Adventitia with Spared Mucosal Integrity: An Extensive Comprehensive Review of a Clinically Occult Entity Within the Spectrum of Non-Muscle-Invasive Upper Tract Disease, Diagnostic Pitfalls, And Dive

Background: Upper tract urothelial carcinoma (UTUC) presenting as an exclusive peri-ureteral mass with infiltration of the adventitial soft tissue whilst maintaining absolute denudation of the overlying ureteric mucosa and lamina propria represents an extraordinarily rare and diagnostically treacherous pathological phenomenon. Unlike conventional invasive UTUC wherein transmural progression follows a sequential centripetal pattern, this non-mucosa-invasive yet peri-ureteral variant violates conventional staging paradigms, creating substantial nosological ambiguity. Current American Joint Committee on Cancer (AJCC) criteria lack explicit designation for neoplasms demonstrating extra-ureteral extension without concomitant subepithelial connective tissue or muscularis propria involvement, engendering a tangible risk for both under-staging and inappropriate therapeutic stratification. Objective: This comprehensive review aims to synthesize the extant, albeit fragmentary, literature concerning peri-ureteral urothelial carcinoma without mucosal involvement, elucidate its putative histogenetic mechanisms—including the prevailing hypothesis of origin within peri-ureteral or von Brunn’s nest remnants—delineate the immunohistochemical challenges in distinguishing this entity from primary peri-ureteral adenocarcinoma or metastatic disease, and critically evaluate the oncological outcomes extrapolated from analogous pT3 subclassification data. Methods: A meticulous narrative synthesis of the literature was conducted, with focused interrogation of multicenter UTUC cohorts, contemporary genomic profiling studies, and institutional case reports to aggregate histomorphological descriptors, immunophenotypic profiles, and survival metrics. Results: Evidence suggests that extra-ureteral tumor extension without mucosal invasion, when stratified within pT3b disease, portends significantly inferior recurrence-free and cancer-specific survival compared to renal parenchymal invasion alone, with five-year cancer-specific survival approximating 54.3% in the largest available series. Furthermore, emerging data implicate distinct clonal evolutionary trajectories and chromatin regulatory gene alterations—particularly involving KMT2C and EP300—which may underpin the paradoxical phenotype of extra-ureteral dissemination without antecedent high-grade intraurothelial carcinoma. Conclusions: Peri-ureteral urothelial carcinoma with spared mucosa constitutes a distinct clinicopathologic entity that defies conventional staging logic and warrants formal recognition within future tumor-nodes-metastasis (TNM) frameworks. A heightened index of suspicion is mandated for ureteric tumors demonstrating eccentric adventitial thickening on cross-sectional imaging in the absence of an intraluminal component. Multidisciplinary collaboration between urologists, radiologists, and genitourinary pathologists is imperative to avert diagnostic oversight and facilitate the administration of risk-adapted perioperative therapeutic strategies.